Hyperpolarized 13C Metabolic MRI of the Human Heart: Initial Experience

Circulation Research

Volumn 119, Issue 11, 2016, Pages 1177-1182

  Cunningham, Charles H ^a,b   Lau, Justin Y C ^a,b   Chen, Albert P ^c   Geraghty, Benjamin J ^a,b   Perks, William J ^d   Roifman, Idan ^d   Wright, Graham A ^a,b,d   Connelly, Kim A ^e  

^a Institute of Clinical Evaluative Sciences   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GE HEALTHCARE   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

heart failure; magnetic resonance imaging; metabolic imaging; metabolism; mitochondria

Indexed keywords

BICARBONATE; CARBON 13; LACTIC ACID; PYRUVIC ACID; CARBON;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY SURFACE; CARDIAC GATED IMAGING; CARDIAC IMAGING; CARDIAC MUSCLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL TRIAL; DISSOLUTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; DIAGNOSTIC IMAGING; HEART; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES;

ADULT; CARBON ISOTOPES; HEART; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PYRUVIC ACID;

EID: 84991492414     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309769     Document Type: Article

References (22)

1. Stanley WC, Chandler MP. Energy metabolism in the normal and failing heart: potential for therapeutic interventions. Heart Fail Rev. 2002;7:115-130.
2. Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007;116:434-448. doi: 10.1161/ CIRCULATIONAHA.107.702795.
3. Ardehali H, Sabbah HN, Burke MA, Sarma S, Liu PP, Cleland JG, Maggioni A, Fonarow GC, Abel ED, Campia U, Gheorghiade M. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail. 2012;14:120-129. doi: 10.1093/eurjhf/ hfr173.
4. Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res. 2013;113:709-724. doi: 10.1161/CIRCRESAHA.113.300376.
5. Garlick PB, Radda GK, Seeley PJ. Phosphorus NMR studies on perfused heart. Biochem Biophys Res Commun. 1977;74:1256-1262.
6. Bailey IA, Gadian DG, Matthews PM, Radda GK, Seeley PJ. Studies of metabolism in the isolated, perfused rat heart using 13C NMR. FEBS Lett. 1981;123:315-318.
7. Ardenkjaer-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100:10158-10163. doi: 10.1073/pnas.1733835100.
8. Merritt ME, Harrison C, Storey C, Jeffrey FM, Sherry AD, Malloy CR. Hyperpolarized 13C allows a direct measure of flux through a single enzyme-catalyzed step by NMR. Proc Natl Acad Sci U S A. 2007;104:19773-19777. doi: 10.1073/pnas.0706235104.
9. Golman K, Petersson JS, Magnusson P, Johansson E, Akeson P, Chai CM, Hansson G, Månsson S. Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med. 2008;59:1005-1013. doi: 10.1002/mrm.21460.
10. Schroeder MA, Cochlin LE, Heather LC, Clarke K, Radda GK, Tyler DJ. In vivo assessment of pyruvate dehydrogenase flux in the heart using hyperpolarized carbon-13 magnetic resonance. Proc Natl Acad Sci U S A. 2008;105:12051-12056. doi: 10.1073/pnas.0805953105.
11. Schroeder MA, Clarke K, Neubauer S, Tyler DJ. Hyperpolarized magnetic resonance: a novel technique for the in vivo assessment of cardiovascular disease. Circulation. 2011;124:1580-1594. doi: 10.1161/ CIRCULATIONAHA.111.024919.
12. Lau AZ, Chen AP, Barry J, Graham JJ, Dominguez-Viqueira W, Ghugre NR, Wright GA, Cunningham CH. Reproducibility study for freebreathing measurements of pyruvate metabolism using hyperpolarized (13) C in the heart. Magn Reson Med. 2013;69:1063-1071. doi: 10.1002/mrm.24342.
13. Schroeder MA, Lau AZ, Chen AP, Gu Y, Nagendran J, Barry J, Hu X, Dyck JR, Tyler DJ, Clarke K, Connelly KA, Wright GA, Cunningham CH. Hyperpolarized (13)C magnetic resonance reveals early-and late-onset changes to in vivo pyruvate metabolism in the failing heart. Eur J Heart Fail. 2013;15:130-140. doi: 10.1093/eurjhf/hfs192.
14. Le Page LM, Rider OJ, Lewis AJ, Ball V, Clarke K, Johansson E, Carr CA, Heather LC, Tyler DJ. Increasing pyruvate dehydrogenase flux as a treatment for diabetic cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study. Diabetes. 2015;64:2735-2743. doi: 10.2337/db14-1560.
15. Lau AZ, Chen AP, Ghugre NR, Ramanan V, Lam WW, Connelly KA, Wright GA, Cunningham CH. Rapid multislice imaging of hyperpolarized 13C pyruvate and bicarbonate in the heart. Magn Reson Med. 2010;64:1323-1331. doi: 10.1002/mrm.22525.
16. Tropp J, Calderon P, Carvajal L, Robb F, Larson PEZ, Shin P, Vigneron DB, Nelson SJ. A carbon receive array of 8 elements, interoperable with proton scanning, for human temporal lobe. Proceedings of the 20th Annual Meeting of ISMRM; Melbourne, Australia. 2012. Abstract 2658.
17. Ardenkjaer-Larsen JH, Leach AM, Clarke N, Urbahn J, Anderson D, Skloss TW. Dynamic nuclear polarization polarizer for sterile use intent. NMR Biomed. 2011;24:927-932.
18. Witney TH, Kettunen MI, Brindle KM. Kinetic modeling of hyperpolarized 13C label exchange between pyruvate and lactate in tumor cells. J Biol Chem. 2011;286:24572-24580. doi: 10.1074/jbc.M111.237727.
19. Rider OJ, Tyler DJ. Clinical implications of cardiac hyperpolarized magnetic resonance imaging. J Cardiovasc Magn Reson. 2013;15:93. doi: 10.1186/1532-429X-15-93.
20. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation. 2002;105:1727-1733.
21. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes. 2004;53:2366-2374.
22. Lewis AJ, Neubauer S, Tyler DJ, Rider OJ. Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy. Expert Opin Ther Targets. 2016;20:755-766. doi: 10.1517/14728222.2016.1126248.